These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8389085)

  • 21. Epstein-Barr virus single-stranded DNA-binding protein: purification, characterization, and action on DNA synthesis by the viral DNA polymerase.
    Tsurumi T; Kobayashi A; Tamai K; Yamada H; Daikoku T; Yamashita Y; Nishiyama Y
    Virology; 1996 Aug; 222(2):352-64. PubMed ID: 8806519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.
    Montone KT; Hodinka RL; Salhany KE; Lavi E; Rostami A; Tomaszewski JE
    Mod Pathol; 1996 Jun; 9(6):621-30. PubMed ID: 8782198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus permissively infects human syncytiotrophoblasts in vitro and induces replication of human T cell leukemia-lymphoma virus type I in dually infected cells.
    Tóth FD; Aboagye-Mathiesen G; Nemes J; Liu X; Andirkó I; Hager H; Zdravkovic M; Szabó J; Kiss J; Aranyosi J; Ebbesen P
    Virology; 1997 Mar; 229(2):400-14. PubMed ID: 9126252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBV-seropositive individuals.
    Bhaduri-McIntosh S; Miller G
    J Virol Methods; 2006 Oct; 137(1):103-14. PubMed ID: 16843536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus and tumor promoters.
    Eliasson L; Nilsson MT; Kallin B; Klein G
    Princess Takamatsu Symp; 1983; 14():139-45. PubMed ID: 6097578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
    Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
    J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus replication in oropharyngeal epithelial cells.
    Sixbey JW; Nedrud JG; Raab-Traub N; Hanes RA; Pagano JS
    N Engl J Med; 1984 May; 310(19):1225-30. PubMed ID: 6323983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence.
    Shimizu N; Takada K
    J Virol; 1993 Jun; 67(6):3240-5. PubMed ID: 8388498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense oligodeoxynucleotides against the BZLF1 transcript inhibit induction of productive Epstein-Barr virus replication.
    Diabata M; Enzinger EM; Monroe JE; Kilkuskie RE; Field AK; Mulder C
    Antiviral Res; 1996 Mar; 29(2-3):243-60. PubMed ID: 8739603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.
    Kudoh A; Fujita M; Kiyono T; Kuzushima K; Sugaya Y; Izuta S; Nishiyama Y; Tsurumi T
    J Virol; 2003 Jan; 77(2):851-61. PubMed ID: 12502801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1.
    Hicks MR; Balesaria S; Medina-Palazon C; Pandya MJ; Woolfson DN; Sinclair AJ
    J Virol; 2001 Jun; 75(11):5381-4. PubMed ID: 11333921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.
    Feederle R; Kost M; Baumann M; Janz A; Drouet E; Hammerschmidt W; Delecluse HJ
    EMBO J; 2000 Jun; 19(12):3080-9. PubMed ID: 10856251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demethylation of the Epstein-barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent. Brief report.
    Falk KI; Ernberg I
    Arch Virol; 1999; 144(11):2219-27. PubMed ID: 10603176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lytic transition of Epstein-Barr virus is imitated by recombinant B-cells.
    Marschall M; Alliger P; Schwarzmann F; Bogedain C; Brand M; Reichelt B; Glaser G; Wolf H
    Arch Virol; 1993; 129(1-4):23-33. PubMed ID: 8385916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymic carcinoma with a defective Epstein-Barr virus encoding the BZLF1 trans-activator.
    Patton DF; Ribeiro RC; Jenkins JJ; Sixbey JW
    J Infect Dis; 1994 Jul; 170(1):7-12. PubMed ID: 8014523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines.
    Sato H; Takimoto T; Tanaka S; Tanaka J; Raab-Traub N
    J Virol; 1990 Nov; 64(11):5295-300. PubMed ID: 2170673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids.
    Gradoville L; Grogan E; Taylor N; Miller G
    Virology; 1990 Oct; 178(2):345-54. PubMed ID: 2171186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame.
    Decaussin G; Leclerc V; Ooka T
    J Virol; 1995 Nov; 69(11):7309-14. PubMed ID: 7474160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA sequence analysis of the EcoRI Dhet fragment of B95-8 Epstein-Barr virus containing the terminal repeat sequences.
    Bankier AT; Deininger PL; Satchwell SC; Baer R; Farrell PJ; Barrell BG
    Mol Biol Med; 1983 Nov; 1(4):425-45. PubMed ID: 6094955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathways of activation of the Epstein-Barr virus productive cycle.
    Sinclair AJ; Brimmell M; Shanahan F; Farrell PJ
    J Virol; 1991 May; 65(5):2237-44. PubMed ID: 1850009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.